Bangladesh approves late-stage trial of China's Sinovac COVID-19 vaccine candidate
Bangladesh has approved a late-stage trial of a potential COVID-19 vaccine developed by China's Sinovac Biotech Ltd in the hope of being a priority recipient for the jab, the health minister said on Thursday. The state medical research agency had given ethical approval to the Phase III trial last month, and now the government has signed off on the research. The approval comes after Bangladesh said this month it was also ready to hold trials of potential COVID-19 vaccines developed by India as it seeks to stem the spread of the pandemic.
from RSSMix.com Mix ID 8260727 https://ift.tt/31yBkWz
Comments
Post a Comment